Persistence with Cholinesterase Inhibitor Treatment in Alzheimer's Disease

被引：4

作者：

Massoud, Fadi ^{[1
]}

机构：

[1] Univ Montreal, Montreal, PQ, Canada

来源：

CANADIAN JOURNAL OF NEUROLOGICAL SCIENCES | 2013年 / 40卷 / 05期

关键词：

DEMENTIA; DISCONTINUATION; THERAPY;

D O I：

10.1017/S0317167100014815

中图分类号：

R74 [神经病学与精神病学];

学科分类号：

摘要：

引用

页码：623 / 624

页数：2

共 50 条

[41] Empirical evidence of neuroprotection by dual cholinesterase inhibition in Alzheimer's disease
Venneri, A
McGeown, WJ
Shanks, MF
NEUROREPORT, 2005, 16 (02) : 107 - 110
[42] Value for money in treating Alzheimer's disease with the new cholinesterase inhibitors
Shah, A
Jenkins, R
INTERNATIONAL JOURNAL OF PSYCHIATRY IN CLINICAL PRACTICE, 2003, 7 (01) : 45 - 47
[43] Donepezil: An anticholinesterase inhibitor for Alzheimer's disease
Shintani, EY
Uchida, KM
AMERICAN JOURNAL OF HEALTH-SYSTEM PHARMACY, 1997, 54 (24) : 2805 - 2810
[44] DISCRIMINATION OF ALZHEIMER PATIENTS RESPONDING TO CHOLINESTERASE INHIBITOR THERAPY
ALHAINEN, K
RIEKKINEN, PJ
ACTA NEUROLOGICA SCANDINAVICA, 1993, 88 : 16 - 21
[45] Memantine treatment in patients with mild to moderate Alzheimer's disease already receiving a cholinesterase inhibitor: A randomized, double-blind, placebo-controlled trial
Porsteinsson, Anton P.
Grossberg, George T.
Mintzer, Jacobo
Olin, Jason T.
CURRENT ALZHEIMER RESEARCH, 2008, 5 (01) : 83 - 89
[46] Utility of an Effect Size Analysis for Communicating Treatment Effectiveness: A Case Study of Cholinesterase Inhibitors for Alzheimer's Disease
Peters, Kevin R.
JOURNAL OF THE AMERICAN GERIATRICS SOCIETY, 2013, 61 (07) : 1170 - 1174
[47] Long-Term Efficacy and Toxicity of Cholinesterase Inhibitors in the Treatment of Alzheimer Disease
Hogan, David B.
CANADIAN JOURNAL OF PSYCHIATRY-REVUE CANADIENNE DE PSYCHIATRIE, 2014, 59 (12): : 618 - 623
[48] Persistent treatment with cholinesterase inhibitors and/or memantine slows clinical progression of Alzheimer disease
Rountree, Susan D.
Chan, Wenyaw
Pavlik, Valory N.
Darby, Eveleen J.
Siddiqui, Samina
Doody, Rachelle S.
ALZHEIMERS RESEARCH & THERAPY, 2009, 1 (02):
[49] Cholinesterase inhibitors as Alzheimer's therapeutics
Sharma, Kamlesh
MOLECULAR MEDICINE REPORTS, 2019, 20 (02) : 1479 - 1487
[50] New acetylcholinesterase inhibitor (donepezil) treatment for Alzheimer's disease in a chronic dialysis patient
Suwata, J
Kamata, K
Nishijima, T
Yoshikawa, T
Sano, M
NEPHRON, 2002, 91 (02): : 330 - 332

← 1 2 3 4 5 →